309 related articles for article (PubMed ID: 30334474)
1. Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.
Strober L; DeLuca J; Benedict RH; Jacobs A; Cohen JA; Chiaravalloti N; Hudson LD; Rudick RA; LaRocca NG;
Mult Scler; 2019 Nov; 25(13):1781-1790. PubMed ID: 30334474
[TBL] [Abstract][Full Text] [Related]
2. The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed.
Berrigan LI; LeFevre JA; Rees LM; Berard JA; Francis A; Freedman MS; Walker LAS
Mult Scler Relat Disord; 2022 Dec; 68():104229. PubMed ID: 36279599
[TBL] [Abstract][Full Text] [Related]
3. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.
Benedict RH; DeLuca J; Phillips G; LaRocca N; Hudson LD; Rudick R;
Mult Scler; 2017 Apr; 23(5):721-733. PubMed ID: 28206827
[TBL] [Abstract][Full Text] [Related]
4. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
[TBL] [Abstract][Full Text] [Related]
6. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
7. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
[TBL] [Abstract][Full Text] [Related]
8. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
Forn C; Belenguer A; Parcet-Ibars MA; Avila C
J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
[TBL] [Abstract][Full Text] [Related]
9. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
[TBL] [Abstract][Full Text] [Related]
10. The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance.
Sandry J; Simonet DV; Brandstadter R; Krieger S; Katz Sand I; Graney RA; Buchanan AV; Lall S; Sumowski JF
Mult Scler Relat Disord; 2021 Jun; 51():102950. PubMed ID: 33887609
[TBL] [Abstract][Full Text] [Related]
11. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
Hansen S; Muenssinger J; Kronhofmann S; Lautenbacher S; Oschmann P; Keune PM
BMC Neurol; 2015 Nov; 15():246. PubMed ID: 26612613
[TBL] [Abstract][Full Text] [Related]
12. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.
Benedict RH; Smerbeck A; Parikh R; Rodgers J; Cadavid D; Erlanger D
Mult Scler; 2012 Sep; 18(9):1320-5. PubMed ID: 22277740
[TBL] [Abstract][Full Text] [Related]
13. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
[TBL] [Abstract][Full Text] [Related]
15. Slowed articulation rate is associated with information processing speed decline in multiple sclerosis: A pilot study.
Friedova L; Rusz J; Motyl J; Srpova B; Vodehnalova K; Andelova M; Novotna K; Novotny M; Ruzickova H; Tykalova T; Kubala Havrdova E; Horakova D; Uher T
J Clin Neurosci; 2019 Jul; 65():28-33. PubMed ID: 31072740
[TBL] [Abstract][Full Text] [Related]
16. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Strober L; Chiaravalloti N; Moore N; DeLuca J
Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909
[TBL] [Abstract][Full Text] [Related]
17. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
[TBL] [Abstract][Full Text] [Related]
18. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
[TBL] [Abstract][Full Text] [Related]
19. The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.
Bigi S; Marrie RA; Till C; Yeh EA; Akbar N; Feinstein A; Banwell BL
Neurol Sci; 2017 Apr; 38(4):635-642. PubMed ID: 28078569
[TBL] [Abstract][Full Text] [Related]
20. Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
Vollmer T; Huynh L; Kelley C; Galebach P; Signorovitch J; DiBernardo A; Sasane R
Neurol Sci; 2016 Feb; 37(2):165-79. PubMed ID: 26537494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
